Skip to content
§Regimen workspace

Where a regimen's kidney risks overlap

Assemble the agents in a regimen once, then read them three ways — the compounded risks where more than one agent hits the same kidney-injury signature (at least one above the rare tier), a side-by-side comparison of their profiles, or one consolidated renal monitoring plan to hand off. Built from the atlas's citation-grounded profiles.

Loading…
Data-viz lensSee the documented onco-onco synergy pairsThe 9 documented anti-cancer combinations whose kidney risk compounds beyond either agent alone, mapped as a network — the hubs that recur across regimens and the phenotype that dominates the synergies.At the bedsideAlready have AKI? Rank the likely culpritAdd the kidney picture you're seeing to a regimen and the Culprit Console ranks which agent is the more likely cause, from documented injury associations, onset, and FAERS signals.

This is an educational overlap view derived from each agent's documented injury signatures, not a validated interaction model — it does not account for dose, sequence, patient factors, or synergy. Medical-education content only — not medical advice. Confirm against primary sources and current guidelines.